The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035092 · Cited by 2,421
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Descombes, P., & Schibler, U. (1991) · Cell · doi:10.1016/0092-8674(91)90531-3 · Cited by 990
Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R., & Ball, S. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000794 · Cited by 928
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
The Biology of Hematopoietic Stem Cells
Morrison, S. J., Uchida, N., & Weissman, I. L. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000343 · Cited by 778
(1975) · The Enzymes · doi:10.1016/s1874-6047(08)60211-5 · Cited by 691
Birkenmeier, E. H., Gwynn, B., Howard, S., Jerry, J., Gordon, J. I., Landschulz, W. H., & McKnight, S. L. (1989) · Genes & Development · doi:10.1101/gad.3.8.1146 · Cited by 613
Krueger, S. K., & Williams, D. E. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.001 · Cited by 567
Lacroix, D., Sonnier, M., Moncion, A., Cheron, G., & Cresteil, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00625.x · Cited by 539
Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530
Liver‐enriched transcription factors and hepatocyte differentiation
Cereghini, S. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.2.8641560 · Cited by 510
EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological Roles
Morisseau, C., & Hammock, B. D. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095920 · Cited by 479
Barter, Z., Bayliss, M., Beaune, P., Boobis, A., Carlile, D., Edwards, R., Brian Houston, J., Lake, B., Lipscomb, J., Pelkonen, O., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779315053 · Cited by 459
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
Messina, E. S., Tyndale, R. F., & Sellers, E. M. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36947-2 · Cited by 453
Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
Lin, Y. S., Dowling, A. L. S., Quigley, S. D., Farin, F. M., Zhang, J., Lamba, J., Schuetz, E. G., & Thummel, K. E. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.162 · Cited by 449
Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).
Wrighton, S. A., Brian, W. R., Sari, M. A., Iwasaki, M., Guengerich, F. P., Raucy, J. L., Molowa, D. T., & Vandenbranden, M. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09441-6 · Cited by 402
Mueller, C. R., Maire, P., & Schibler, U. (1990) · Cell · doi:10.1016/0092-8674(90)90808-r · Cited by 393
Glucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393
Analysis of the glutathione S-transferase (GST) gene family
Nebert, D. W., & Vasiliou, V. (2004) · Human Genomics · doi:10.1186/1479-7364-1-6-460 · Cited by 387
The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
Yamano, S., Tatsuno, J., & Gonzalez, F. J. (1990) · Biochemistry · doi:10.1021/bi00457a031 · Cited by 383
Developmental changes and polymorphism in human alcohol dehydrogenase
SMITH, M., HOPKINSON, D. A., & HARRIS, H. (1971) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1971.tb00238.x · Cited by 369
Developmental Expression of the Major Human Hepatic CYP3A Enzymes
Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J., & Zaya, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054841 · Cited by 368
Self-citationMcCarver, D. G., & Hines, R. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.361 · Cited by 366
Self-citationThe Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes
Hines, R. N., & McCarver, D. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.355 · Cited by 365
Self-citationEvidence That CYP2C19 is the Major (S)-Mephenytoin 4'-Hydroxylase in Humans
Goldstein, J. A., Faletto, M. B., Romkes-Sparks, M., Sullivan, T., Kitareewan, S., Raucy, J. L., Lasker, J. M., & Ghanayem, B. I. (1994) · Biochemistry · doi:10.1021/bi00173a017 · Cited by 360
Weiss, C. F., Glazko, A. J., & Weston, J. K. (1960) · New England Journal of Medicine · doi:10.1056/nejm196004212621601 · Cited by 352
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 341
McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu, S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R., Lubet, R. A., et al. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.16.1333 · Cited by 340
Self-citationSu, T., Bao, Z., Zhang, Q., Smith, T. J., Hong, J., & Ding, X. (2000) · PubMed · Cited by 339
Developmental Expression of Human Hepatic CYP2C9 and CYP2C19
Koukouritaki, S. B., Manro, J. R., Marsh, S. A., Stevens, J. C., Rettie, A. E., McCarver, D. G., & Hines, R. N. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060137 · Cited by 325
Self-citationA proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily
Blanchard, R. L., Freimuth, R. R., Buck, J., Weinshilboum, R. M., & Coughtrie, M. W. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00009 · Cited by 320
McManus, M. E., Burgess, W. M., Veronese, M., Huggett, A. C., Quattrochi, L. C., & Tukey, R. H. (1990) · PubMed · Cited by 289
Developmental aspects of human hepatic drug glucuronidation in young children and adults
Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., & Manns, M. P. (2002) · Gut · doi:10.1136/gut.50.2.259 · Cited by 288
Kiefer, J. C. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21094 · Cited by 285
Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver
Schuetz, J. D., Beach, D. L., & Guzelian, P. S. (1994) · Pharmacogenetics · doi:10.1097/00008571-199402000-00002 · Cited by 273
Pharmacokinetics in the newborn
Alcorn, J., & McNamara, P. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00030-9 · Cited by 266
Vieira, I., Sonnier, M., & Cresteil, T. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0476z.x · Cited by 265
Absorption, metabolism, and excretion of risperidone in humans.
Mannens, G., Huang, M. L., Meuldermans, W., Hendrickx, J., Woestenborghs, R., & Heykants, J. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08211-x · Cited by 261
Cuzzolin, L., Atzei, A., & Fanos, V. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.5.703 · Cited by 252
Rifkind, A. B., Lee, C., Chang, T. K. H., & Waxman, D. J. (1995) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(95)90023-3 · Cited by 251
Drolet, D. W., Scully, K. M., Simmons, D. M., Wegner, M., Chu, K. T., Swanson, L. W., & Rosenfeld, M. G. (1991) · Genes & Development · doi:10.1101/gad.5.10.1739 · Cited by 246
Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression
Koukouritaki, S. B., Simpson, P., Yeung, C. K., Rettie, A. E., & Hines, R. N. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00018 · Cited by 245
Self-citationExpression of hepatic transcription factors during liver development and oval cell differentiation.
Nagy, P., Bisgaard, H. C., & Thorgeirsson, S. S. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.223 · Cited by 233
Delayed ontogenesis of CYP1A2 in the human liver
Sonnier, M., & Cresteil, T. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510893.x · Cited by 231
Identification of Human Liver Cytochrome P450 Isoforms Mediating Omeprazole Metabolism
ANDERSSON, T., MINERS, J. O., VERONESE, M. E., TASSANEEYAKUL, W., TASSANEEYAKUL, W., MEYER, U. A., & BIRKETT, D. J. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb00410.x · Cited by 230
Expression of CYP2D6 in developing human liver
TRELUYER, J., JACQZ‐AIGRAIN, E., ALVAREZ, F., & CRESTEIL, T. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16411.x · Cited by 212
Schrem, H., Klempnauer, J., & Borlak, J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.5 · Cited by 211
Size, Myths and the Clinical Pharmacokinetics of Analgesia in Paediatric Patients
Anderson, B. J., McKee, A. D., & Holford, N. H. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00001 · Cited by 210
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver
Hakkola, J., Pasanen, M., Purkunen, R., Saarikoski, S., Pelkonen, O., Mäenpää, J., Rane, A., & Raunio, H. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90223-2 · Cited by 206
Hakkola, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.2.391 · Cited by 205
Protein binding predictions in infants
McNamara, P. J., & Alcorn, J. (2002) · AAPS PharmSci · doi:10.1208/ps040104 · Cited by 204
Richard, K., Hume, R., Kaptein, E., Stanley, E. L., Visser, T. J., & Coughtrie, M. W. H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7569 · Cited by 204
Cytochrome P450 2E1: its clinical and toxicological role
Tanaka, Terada, & Misawa (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00282.x · Cited by 203
Fetus-specific expression of a form of cytochrome P-450 in human livers
Komori, M., Nishio, K., Kitada, M., Shiramatsu, K., Muroya, K., Soma, M., Nagashima, K., & Kamataki, T. (1990) · Biochemistry · doi:10.1021/bi00470a024 · Cited by 201
Moltke, L. L., Greenblatt, D. J., Giancarlo, G. M., et al. (2001) · PubMed · Cited by 200
Clewell, H. J., Gentry, P. R., Covington, T. R., Sarangapani, R., & Teeguarden, J. G. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh109 · Cited by 193
Omiecinski, C. J., Redlich, C. A., & Costa, P. (1990) · PubMed · Cited by 187
Treluyer, J.-M., Gueret, G., Cheron, G., Sonnier, M., & Cresteil, T. (1997) · Pharmacogenetics · doi:10.1097/00008571-199712000-00002 · Cited by 178
The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism
Costa, L. G., Li, W. F., Richter, R. J., Shih, D. M., Lusis, A., & Furlong, C. E. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00055-1 · Cited by 176
Hernandez, D., Janmohamed, A., Chandan, P., Phillips, I. R., & Shephard, E. A. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00006 · Cited by 173
Miki, Y., Nakata, T., Suzuki, T., Darnel, A. D., Moriya, T., Kaneko, C., Hidaka, K., Shiotsu, Y., Kusaka, H., & Sasano, H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020670 · Cited by 171
Ontogeny of Dextromethorphan O- and N-demethylation in the First Year of Life
Blake, M. J., Gaedigk, A., Pearce, R. E., Bomgaars, L. R., Christensen, M. L., Stowe, C., James, L. P., Wilson, J. T., Kearns, G. L., & Leeder, J. S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100101 · Cited by 169
Human Hepatic CYP2E1 Expression during Development
Johnsrud, E. K., Koukouritaki, S. B., Divakaran, K., Brunengraber, L. L., Hines, R. N., & McCarver, D. G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.053124 · Cited by 167
Self-citationShou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., & Gelboin, H. V. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940100307 · Cited by 167
Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9.
Daikh, B. E., Lasker, J. M., Raucy, J. L., & Koop, D. R. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24028-9 · Cited by 165
Ginsberg, G., Hattis, D., Russ, A., & Sonawane, B. (2004) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287390490273550 · Cited by 161
Richard, K. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2734 · Cited by 158
McCarver, D. G., Byun, R., Hines, R. N., Hichme, M., & Wegenek, W. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8532 · Cited by 155
Self-citationNOVAK, R. F., & Woodcroft, K. J. (2000) · Archives of Pharmacal Research · doi:10.1007/bf02975435 · Cited by 154
Dolphin, C. T., Cullingford, T. E., Shcphard, E. A., Smith, R. L., & Phillips, I. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00683.x · Cited by 152
Antidepressant Drug Interactions and the Cytochrome P450 System
Ereshefsky, L., Riesenman, C., & Lam, Y. W. F. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199500291-00004 · Cited by 151
Oral Anticoagulation Therapy in Pediatric Patients: a Prospective Study
Andrew, M. E., Marzinotto, V., Brooker, L. A., Adams, M., Ginsberg, J., Freedom, R. M., & Williams, W. G. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642427 · Cited by 150
Crespi, C. L., Penman, B. W., Leakey, J., Arlotto, M. P., Stark, A., Parkinson, A., Turner, T., Steimel, D. T., Rudo, K., Davies, R. L., et al. (1990) · Carcinogenesis · doi:10.1093/carcin/11.8.1293 · Cited by 146
Estonius, M., Svensson, S., & Höög, J. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01204-5 · Cited by 145
QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES
Zhang, J., & Cashman, J. R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006171 · Cited by 144
Regulation of the mammalian alcohol dehydrogenase genes
Edenberg, H. J. (2000) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(00)64008-4 · Cited by 140
Variability of CYP3A7 expression in human fetal liver
Leeder, J. S., Gaedigk, R., Marcucci, K. A., Gaedigk, A., Vyhlidal, C. A., Schindel, B. P., & Pearce, R. E. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086504 · Cited by 136
Edwards, R. J., Adams, D. A., Watts, P. S., Davies, D. S., & Boobis, A. R. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00033-1 · Cited by 134
Identification of the Human Cytochromes P450 Responsible for Atomoxetine Metabolism
Ring, B. J., Gillespie, J. S., Eckstein, J. A., & Wrighton, S. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.3.319 · Cited by 133
Takahashi, H. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110977 · Cited by 133
Lee, J. T., Kroemer, H. K., Silberstein, D. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006213222502 · Cited by 132
Immunoquantitation of FMO1 in Human Liver, Kidney, and Intestine
Yeung, C. K., Lang, D. H., Thummel, K. E., & Rettie, A. E. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15194-x · Cited by 132
Fetal hepatic drug elimination
Ring, J. A., Ghabrial, H., Ching, M. S., Smallwood, R. A., & Morgan, D. J. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00046-7 · Cited by 131
Liver volume as a determinant of drug clearance in children and adolescents.
Murry, D. J., Crom, W. R., Reddick, W. E., Bhargava, R., & Evans, W. E. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06755-8 · Cited by 120
Human SULT1A1 gene: copy number differences and functional implications
Hebbring, S. J., Adjei, A. A., Baer, J. L., Jenkins, G. D., Zhang, J., Cunningham, J. M., Schaid, D. J., Weinshilboum, R. M., & Thibodeau, S. N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl468 · Cited by 117
Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
Loughnan, P. M., Greenwald, A., Purton, W. W., Aranda, J. V., Watters, G. V., & Neims, A. H. (1977) · Archives of Disease in Childhood · doi:10.1136/adc.52.4.302 · Cited by 116
Her, C., Kaur, G. P., Athwal, R. S., & Weinshilboum, R. M. (1997) · Genomics · doi:10.1006/geno.1997.4683 · Cited by 116
Barker, E. V., Hume, R., Hallas, A., & Coughtrie, M. W. H. (1994) · Endocrinology · doi:10.1210/endo.134.2.8299591 · Cited by 115
Stanley, E. L., Hume, R., & Coughtrie, M. W. H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.06.003 · Cited by 115
Expression of human paraoxonase (PON1) during development
Cole, T. B., Jampsa, R. L., Walter, B. J., Arndt, T. L., Richter, R. J., Shih, D. M., Tward, A. D., Lusis, A. J., Jack, R. M., Costa, L. G., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200306000-00007 · Cited by 110
Sim, S. C., Edwards, R. J., Boobis, A. R., & Ingelman‐Sundberg, M. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000171516.84139.89 · Cited by 107
Duanmu, Z., Weckle, A. L., Koukouritaki, S. B., Hines, R. N., Falany, J. L., Falany, C. N., Kocarek, T. A., & Runge‐Morris, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093633 · Cited by 107
Self-citationBiotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.
Cazeneuve, C., Pons, G., Rey, E., Tréluyer, J., Cresteil, T., Thiroux, G., d’Athis, P., & Olivé, G. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb05706.x · Cited by 106
Cresteil, T., Beaune, P. H., Kremers, P. G., Célier, C., Guengerich, F. P., & Leroux, J. P. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09107.x · Cited by 105
Carpenter, S. P., Lasker, J. M., & Raucy, J. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08707-3 · Cited by 104
Expression and alternative splicing of the cytochrome P-450 CYP2A7
Ding, S., Lake, B. G., Friedberg, T., & Wolf, C. R. (1995) · Biochemical Journal · doi:10.1042/bj3060161 · Cited by 95
Epirubicin Glucuronidation and UGT2B7 Developmental Expression
Zaya, M. J., Hines, R. N., & Stevens, J. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011387 · Cited by 92
Self-citationTranscriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain
Cowell, I. G., & Hurst, H. C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.1.59 · Cited by 91
Age-related differences in salicylamide and acetaminophen conjugation in man
Alam, S. N., Roberts, R. J., & Fischer, L. J. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80787-7 · Cited by 90
Sohn, D., Kwon, J., Kim, H.-K., & Ishizaki, T. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90137-5 · Cited by 89
Effect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants
Blake, M. J., Abdel‐Rahman, S. M., Pearce, R. E., Leeder, J. S., & Kearns, G. L. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000245909.74166.00 · Cited by 87
Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
Yang, H., Lee, Q. P., Rettie, A. E., & Juchau, M. R. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09834-7 · Cited by 86
Hakkola, J., Raunio, H., Purkunen, R., Saarikoski, S., Vähäkangas, K., Pelkonen, O., Edwards, R. J., Boobis, A. R., & Pasanen, M. (2001) · Neonatology · doi:10.1159/000047142 · Cited by 82
Zhang, X., Zhang, Q.-Y., Liu, D., Su, T., Weng, Y., Ling, G., Chen, Y., Gu, J., Schilling, B., & Ding, X. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005769 · Cited by 82
Maturation of caffeine metabolic pathways in infancy
Carrier, O., Pons, G., Rey, E., Richard, M., Moran, C., Badoual, J., & Olivé, G. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.129 · Cited by 81
Ladona, M., Lindström, B., Thyr, C., et al. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb03902.x · Cited by 79
Krause, R. J., Lash, L. H., & Elfarra, A. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042911 · Cited by 79
Development of CYP2D6 and CYP3A4 in the First Year of Life
Johnson, T., Tucker, G., & Rostami‐Hodjegan, A. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100327 · Cited by 75
Cisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny
Kearns, G. L., Robinson, P. K., Wilson, J. T., Wilson-Costello, D., Knight, G. R., Ward, R. M., & van den Anker, J. N. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00225-x · Cited by 74
Catalysis of the 4-Hydroxylation of Retinoic Acids by Cyp3a7 in Human Fetal Hepatic Tissues
Chen, H., Fantel, A. G., & Juchau, M. R. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15185-9 · Cited by 72
NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSION
Vyhlidal, C. A., Gaedigk, R., & Leeder, J. S. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005967 · Cited by 72
Martinez‐Jimenez, C. P., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008169 · Cited by 67
Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies
Hildebrandt, M. A. T., Salavaggione, O. E., Martin, Y. N., Flynn, H. C., Jalal, S. M., Wieben, E. D., & Weinshilboum, R. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.038 · Cited by 63
Jones, S., Boobis, A. R., Moore, G. E., & Stanier, P. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90726-y · Cited by 63
Phenytoin elimination in newborns
Bourgeois, B. F. D., & Dodson, W. E. (1983) · Neurology · doi:10.1212/wnl.33.2.173 · Cited by 63
Wrighton, S. A., Molowa, D. T., & Guzelian, P. S. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90299-7 · Cited by 54
Kitada, M., Taneda, M., Itahashi, K., & Kamataki, T. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01866.x · Cited by 54
Transient trimethylaminuria in childhood
Mayatepek, D. K. E., & Kohlmüller, D. (1998) · Acta Paediatrica · doi:10.1080/080352598750031257 · Cited by 54
Expression of functional cytochrome P4501A1 in human embryonic hepatic tissues during organogenesis
Yang, H.-Y. L., Namkung, M. J., & Juchau, M. R. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00493-6 · Cited by 52
Cytochrome P450IA expression in adult and fetal human liver
Murray, G. I., Foster, C. O., Barnes, T. S., Weaver, R. J., Snyder, C. P., Ewen, S. W. B., Melvin, W. T., & Burke, M. D. (1992) · Carcinogenesis · doi:10.1093/carcin/13.2.165 · Cited by 50
Evidence of impaired cisapride metabolism in neonates
Tréluyer, J., Rey, E., Sonnier, M., et al. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01470.x · Cited by 49
Delay in Caffeine Elimination in Breast-Fed Infants
Guennec, J. C. L., & Billon, B. (1987) · PEDIATRICS · doi:10.1542/peds.79.2.264 · Cited by 47
Oxidative Metabolism of Amprenavir in the Human Liver. Effect of the CYP3A Maturation
Tréluyer, J., Bowers, G. D., Cazali, N., Sonnier, M., Rey, E., Pons, G., & Cresteil, T. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.3.275 · Cited by 46
Vieira, I., Pasanen, M., Raunio, H., & Cresteil, T. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01466.x · Cited by 46
Ourlin, J.-C., Jounaïdi, Y., Maurel, P., & Vilarem, M. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80497-7 · Cited by 42
Developmental Changes of Aldehyde Oxidase Activity in Young Japanese Children
Tayama, Y., Miyake, K., Sugihara, K., Kitamura, S., Kobayashi, M., Morita, S., Ohta, S., & Kihira, K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100078 · Cited by 42
Mäenpää, J., Rane, A., Raunio, H., Honkakoski, P., & Pelkonen, O. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90175-v · Cited by 41
Cowell, I. G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.18.3607 · Cited by 40
Pearce, R. E., Gotschall, R. R., Kearns, G. L., & Leeder, J. S. (2001) · PubMed · Cited by 40
Hume, R., Barker, E. V., & Coughtrie, M. W. H. (1996) · Histochemistry and Cell Biology · doi:10.1007/bf01696154 · Cited by 39
Shephard, E. A., Chandan, P., Stevanovic-Walker, M., Edwards, M., & Phillips, I. R. (2007) · Biochemical Journal · doi:10.1042/bj20070523 · Cited by 38
Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans
Deininger, E., Oltmanns, K. M., Wellhoener, P., Fruehwald‐Schultes, B., Kern, W., Heuer, B., Dominiak, P., Jan Born, A., Fehm, H. L., & Peters, A. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)26448-0 · Cited by 38
Lieshout, E. M. M. V., Knapen, M. F. C. M., Lange, W., Steegers, E. A. P., & Peters, W. H. M. (1998) · Human Reproduction · doi:10.1093/humrep/13.5.1380 · Cited by 37
Raunio, H., Valtonen, J. M., Honkakoski, P., et al. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90092-y · Cited by 34
Boutelet-Bochan, H., Huang, Y., & Juchau, M. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7296 · Cited by 34
Transcriptional Repression of Human Hepatitis B Virus Genes by a bZIP Family Member, E4BP4
Lai, C.-K., & Ting, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3197-3209.1999 · Cited by 34
Luo, Z., & Hines, R. N. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1421 · Cited by 31
Self-citationCYP2D7 splice variants in human liver and brain: Does CYP2D7 encode functional protein?
Gaedigk, A., Gaedigk, R., & Leeder, J. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.255 · Cited by 30
Lee, Q. P., Fantel, A. G., & Juchau, M. R. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90244-y · Cited by 29
Pasanen, M., Pelkonen, O., Kauppila, A., Park, S., Friedman, F. K., & Gelboin, H. V. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457737 · Cited by 29
Drug-metabolizing enzymes in human foetal liver: partial resolution of multiple cytochromes P 450.
Cresteil, T., Beaune, P. H., Kremers, P. G., Flinois, J.-P., & Leroux, J. P. (1982) · PubMed · Cited by 27
Endrizzi, K., Fischer, J., Klein, K., Schwab, M. G., Nussler, A. K., Neuhaus, P., Eichelbaum, M. F., & Zanger, U. M. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5453 · Cited by 26
Biogenesis of peroxisomes in fetal liver
Espeel, M., Depreter, M., Nardacci, R., D'Herde, K. G. M. A., Kerckaert, I., Stefanini, S., & Roels, F. (1997) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19971201)39:5<424::aid-jemt5>3.0.co;2-g · Cited by 26
Khalighi, M., Brzezinski, M. R., Chen, H., & Juchau, M. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00362-1 · Cited by 24
MITSUKAZUKITADA, TOSHIYAKATO, SHIGERUOHMORI, TETSUYAKAMATAKI, KOSHIROITAHASHI, PETERGUENGERICH, F., TADAAKIRIKIHISA, & YOSHIOKANAKUBO (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90028-s · Cited by 24
Debrisoquine and dextromethorphan phenotyping and antidepressant treatment.
Perault, M. C., Bouquet, S., Bertschy, G., Vandel, S., Chakroun, R., Guibert, S., & Vandel, B. (1991) · PubMed · Cited by 18
Cited by
Developmental Changes in Pharmacokinetics and Pharmacodynamics
van den Anker, J., Reed, M. D., Allegaert, K., & Kearns, G. L. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1284 · Cited by 389
Developmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Paediatric pharmacokinetics: key considerations
Batchelor, H. K., & Marriott, J. F. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12267 · Cited by 355
Staatz, C. E., Goodman, L. K., & Tett, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11317550-000000000-00000 · Cited by 343
Staatz, C. E., Goodman, L. K., & Tett, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11317350-000000000-00000 · Cited by 336
Metadata
- Authors
- Hines, R. N.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 118
- Issue
- 2
- Pages
- 250-267
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2052925329
- Cited by
- 410
- References
- 153
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.